Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DA-EPOCH-Rituximab in Pediatric Primary Mediastinal Large B-Cell Lymphoma
NCT01516567Phase 2Completed
- Sponsor
- Gustave Roussy
- Start
- Apr 2012
- Primary completion
- Apr 2017
- Modality
- Monoclonal Antibodies
- Countries
- 9
01
Overview
A Phase 2 trial of rituximab in primary mediastinal large B-cell lymphoma (PMBCL), sponsored by Gustave Roussy. Started Apr 2012; status: completed.
02
Drugs
rituximab
03
Conditions
primary mediastinal large B-cell lymphoma (PMBCL)
Beyond the preview
Go deeper on NCT01516567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01516567.